In our study, EZH2 expression was found to be significantly and gradually increased from normal cervical tissues to cervical cancer in situ tissues and then to cervical cancer tissues (Figure 1), in agreement with the results of previous studies of cervical cancer [20], prostate cancer [11] and breast carcinoma [52]. This evidence concerns the gene EZH2 and Familial prostate cancer.